Chu Caen - Hôpital de La Côte de Nacre

Caen 14033

1 studies enrolling now · 6 studies all time

What they study most

Advanced Lung Cancer, Hepatocellular Carcinoma, Immune Thrombocytopenia, Lung Cancer, Metastatic Lung Cancer, Multiple Sclerosis, Relapsing-Remitting, NSCLC, Non-Small Cell Lung Cancer, SCLC, Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer, Stage IV Lung Cancer

Studies at this site

• Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders — Recruiting now
• A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD) — Completed
• A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152) — Running, not enrolling
• A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration — Completed
• rVWF IN PROPHYLAXIS — Completed
• A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations — Stopped early